Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Plos One
|
February 8, 2018
A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy
Takako Jones, Peter L Jones
Transgenic Research
|
April 21, 2007
Engineered telomeres in transgenic Xenopus laevis
Ryan Wuebbles, Peter L Jones
Annual Review of Genomics and Human Genetics
|
April 25, 2019
The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy
Charis L Himeda, Peter L Jones
Journal of Personalized Medicine
|
June 24, 2022
FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?
Charis L Himeda, Peter L Jones
Developmental Cell
|
September 11, 2019
The Good, The Bad, and The Unexpected: Roles of DUX4 in Health and Disease
Charis L Himeda, Peter L Jones
Diagnostics (Basel, Switzerland)
|
August 27, 2021
Precise Epigenetic Analysis Using Targeted Bisulfite Genomic Sequencing Distinguishes FSHD1, FSHD2, and Healthy Subjects
Taylor Gould, Takako I Jones, Peter L Jones
Plos One
|
March 5, 2016
Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD)
Takako I Jones, Megan Parilla, Peter L Jones
Bioinformatics (Oxford, England)
|
March 20, 2012
BioQ: tracing experimental origins in public genomic databases using a novel data provenance model
Scott F Saccone, Jiaxi Quan, Peter L Jones
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 4, 2015
CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy
Charis L Himeda, Takako I Jones, Peter L Jones
Disease Models & Mechanisms
|
April 23, 2009
FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy
Ryan D Wuebbles, Meredith L Hanel, Peter L Jones
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Plos One
|
February 8, 2018
A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy
Takako Jones, Peter L Jones
Transgenic Research
|
April 21, 2007
Engineered telomeres in transgenic Xenopus laevis
Ryan Wuebbles, Peter L Jones
Annual Review of Genomics and Human Genetics
|
April 25, 2019
The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy
Charis L Himeda, Peter L Jones
Journal of Personalized Medicine
|
June 24, 2022
FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?
Charis L Himeda, Peter L Jones
Developmental Cell
|
September 11, 2019
The Good, The Bad, and The Unexpected: Roles of DUX4 in Health and Disease
Charis L Himeda, Peter L Jones
Diagnostics (Basel, Switzerland)
|
August 27, 2021
Precise Epigenetic Analysis Using Targeted Bisulfite Genomic Sequencing Distinguishes FSHD1, FSHD2, and Healthy Subjects
Taylor Gould, Takako I Jones, Peter L Jones
Plos One
|
March 5, 2016
Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD)
Takako I Jones, Megan Parilla, Peter L Jones
Bioinformatics (Oxford, England)
|
March 20, 2012
BioQ: tracing experimental origins in public genomic databases using a novel data provenance model
Scott F Saccone, Jiaxi Quan, Peter L Jones
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 4, 2015
CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy
Charis L Himeda, Takako I Jones, Peter L Jones
Disease Models & Mechanisms
|
April 23, 2009
FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy
Ryan D Wuebbles, Meredith L Hanel, Peter L Jones
Page
of 8